MarketPulse

nasal polyps

2 articles
BenzingaBenzinga··Vandana Singh

Sanofi's Dual-Action Drug Shows Promise Beyond Lungs in Asthma, Polyp Trials

Sanofi's lunsekimig met primary endpoints in asthma and nasal polyp trials but failed dermatitis goals, showing favorable safety across all studies.
SNYUPBREGNGSKatopic dermatitisPhase 2 trials
BenzingaBenzinga··Vandana Singh

FDA Expands Dupixent Approval to Allergic Fungal Rhinosinusitis

FDA approves Dupixent for allergic fungal rhinosinusitis in patients six and older, marking the drug's ninth indication for treating type 2 inflammatory conditions.
SNYREGNFDA approvalPhase 3 trial